Antegrade common bile duct (CBD) stenting after laparoscopic CBD exploration

Cholelithiasis and choledocholithiasis remain significant causes of morbidity requiring surgical intervention. Prior research has shown that laparoscopic techniques have largely replaced open procedures due to reduced recovery times and lower complication rates. Established knowledge includes the effectiveness of laparoscopic cholecystectomy in gallstone disease. That uncertainty drove the need to evaluate alternative approaches for bile duct clearance. No prior work had resolved the optimal method for CBD closure after exploration. Existing data suggest that T-tubes and biliary anastomoses are standard options. This gap motivated investigation into antegrade stenting as a viable alternative. The procedure may be performed safely in expert hands without mortality and with negligible morbidity.

The aim of the study was to evaluate antegrade CBD stenting as a primary closure method after laparoscopic CBD exploration. The specific problem addressed is the need for alternative drainage methods following stone clearance. Motivation arose from the limitations of T-tubes and biliary anastomoses in certain clinical scenarios. The study focused on safety, feasibility, and outcomes of this technique. It was already known that LCBDE is a standard procedure for choledocholithiasis. This gap motivated the investigation into whether stenting could replace traditional drainage methods. The study sought to confirm whether this approach could be performed safely in expert hands. The researchers propose that antegrade stenting may offer a viable alternative to existing techniques.

The study involved 100 patients with choledocholithiasis who underwent LCBDE followed by antegrade stenting. CBD exploration was achieved through direct massage, saline lavage, or basketing techniques. A pediatric bronchoscope was used for completion choledochoscopy. A 10-cm, 7 Fr. double-flap stent was placed after stone clearance. The procedure required advanced endosuturing skills for CBD closure. No T-tubes or anastomoses were used in these cases. Postoperative outcomes were tracked for complications and hospital stay duration. Stents were removed endoscopically after four weeks of placement.

The study reported a 100% success rate in stone clearance with no mortality observed. The median operation duration was 75 minutes, and the mean hospital stay was 3.5 days. One patient experienced a minor biliary leak, and another had a sub-hepatic collection. Four patients developed port-site infections, but no major complications occurred. Stents were removed endoscopically after four weeks without issues. Sixty-eight patients were followed up for one year with no residual disease. All patients remained asymptomatic during follow-up. The researchers propose that this method is a safe and viable option in expert hands.

The authors suggest that antegrade stenting after LCBDE is a feasible and safe option for CBD closure. No mortality was observed in the study cohort, and complications were minimal. The procedure requires advanced skills in minimal access surgery, particularly endosuturing. The researchers propose that this approach may replace traditional drainage methods in select cases. No prior work had resolved the optimal method for CBD closure after exploration. The study supports the viability of this technique in expert hands. The authors suggest that this method may reduce the need for T-tubes or anastomoses. The findings indicate that antegrade stenting is a cost-effective option for bile duct closure.